Under og efter behandling skal disse patienter monitoreres tæt for kliniske, biokemiske og virologiske parametre, der associeres med hepatitis B.
These patients should be closely monitored for clinical, biochemical and virological parameters associated with hepatitis B during treatment and after treatment is discontinued.